Mangoceuticals, Inc. (MGRX) vs Skye Bioscience, Inc. (SKYE)

A side-by-side comparison of Mangoceuticals, Inc. and Skye Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Mangoceuticals, Inc. logo
MGRX
Mangoceuticals, Inc.
$7M
$0.41HealthcareDelayed quote: Oct 6, 2026, 1:01 PM EDT
Skye Bioscience, Inc. logo
SKYE
Skye Bioscience, Inc.
$7M
$1.69HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT

Total return — MGRX vs SKYE

growth of $100 · dividends reinvested · last 4y
MGRX -99.3% (-71.1%/yr)SKYE -96.2% (-56.0%/yr)SKYE compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202420252026$1$4
MGRX SKYE

MGRX vs SKYE: by the numbers

  • •SKYE is the larger company ($7M vs $7M market cap).
  • •Both run net losses; SKYE's is the smaller (0.00% vs -4791.48% net margin).

Metrics side by side

Valuation

MetricMGRXSKYE
P/S ratio22.20N/A
P/B ratio0.56N/A

Profitability

MetricMGRXSKYE
Gross margin54.43%0.00%
Operating margin-4200.46%0.00%
Net margin-4791.48%0.00%
ROE-120.58%N/A
ROIC-102.91%N/A

Growth (annualized)

MetricMGRXSKYE
Total return CAGR (5Y)N/A-60.42%

Go deeper

Full MGRX analysisFull SKYE analysisInteractive comparison tool

Dig into the metrics

Mangoceuticals ROESkye Bioscience ROEMangoceuticals operating marginSkye Bioscience operating marginMangoceuticals revenue growthSkye Bioscience revenue growthMangoceuticals free cash flowSkye Bioscience free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.